CVR number 39683520
Industry 21.2000 Manufacture of pharmaceutical preparations

LactaPure IVS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

   
Loading...
Bankruptcy Risk 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 26.0% 30.3%  
Credit score (0-100)  0 0 0 3 1  
Credit rating  N/A N/A N/A B C  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Net sales  0 0 0 8 0  
Gross profit  0.0 0.0 0.0 7.7 0.0  
EBITDA  0.0 0.0 0.0 7.7 0.0  
EBIT  0.0 0.0 0.0 7.7 0.0  
Pre-tax profit (PTP)  0.0 0.0 0.0 7.7 0.0  
Net earnings  0.0 0.0 0.0 7.7 0.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 7.7 0.0  
 
See the entire income statement

Balance sheet (kDKK) 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 7.7 7.7  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 7.7 7.7  
Net Debt  0.0 0.0 0.0 -7.7 -7.7  
 
See the entire balance sheet

Volume 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Net sales  0 0 0 8 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% -100.0%  
Gross profit  0.0 0.0 0.0 7.7 0.0  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -100.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 8 8  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 0.0%  
Added value  0.0 0.0 0.0 7.7 0.0  
Added value %  0.0% 0.0% 0.0% 100.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 -1.0  
EBIT trend  0.0 0.0 0.0 1.0 0.0  

Profitability 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
EBITDA %  0.0% 0.0% 0.0% 100.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 100.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 100.0% 0.0%  
Net Earnings %  0.0% 0.0% 0.0% 100.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 100.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 100.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 100.0% 0.0%  
ROI %  0.0% 0.0% 0.0% 100.0% 0.0%  
ROE %  0.0% 0.0% 0.0% 100.0% 0.0%  

Solidity 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Equity ratio %  0.0% 0.0% 0.0% 100.0% 100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% -100.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -100.0% 0.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  0.0 0.0 0.0 7.7 7.7  

Capital use efficiency 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 100.0% 0.0%  
Net working capital  0.0 0.0 0.0 7.7 7.7  
Net working capital %  0.0% 0.0% 0.0% 100.0% 0.0%  

Employee efficiency 
2016
N/A
2017
N/A
2018
N/A
2019
2019/8
2020
2020/8
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0